HomeMarket NewsPROCEPT BioRobotics gets FDA okay for prostate cancer study

PROCEPT BioRobotics gets FDA okay for prostate cancer study

Actionable Trade Ideas

always free

Prostate cancer diagnosis on a medical form.

designer491/iStock through Getty Pictures

PROCEPT BioRobotics (NASDAQ:PRCT) mentioned it has obtained FDA approval to conduct a research investigating the protection and efficacy of Aquablation remedy within the remedy of prostate most cancers.

PROCEPT mentioned the research’s findings can be used to help future analysis and

Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.